This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Managing Sleep Disturbances in Psychiatric Patients

Managing Sleep Disturbances in Psychiatric Patients

Format

Webcast

Time to Complete

1 hour

Released

August 18, 2015

Expires

August 18, 2016
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / CE for Nurse Practitioners; includes 0.36 pharmacology credits
1.20 / CE for Nurses

Accredited Provider



Provided by Postgraduate Institute for Medicine (PIM)

Commercial Supporter

Supported by independent educational grants from Forest, Jazz, Lundbeck, Merk, Sunovion, and Takeda Pharmaceuticals

Program Description

The GME Psychiatry Update highlights the latest advances in diagnostic and therapeutic issues in patients with bipolar disorder, major depression, and sleep disturbances. This will include reasons for missed diagnosis, changes in DSM-5, and comorbidities. The latest advances in treating all phases of the illness including treatment resistant patients, non-pharmacological therapies, side effects of psychotropics and strategies to make patients active collaborators in their care will be discussed.

Intended Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, and registered nurses who care for patients with psychiatric illnesses.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Discuss the diagnosis and management of sleep disorders in psychiatric patients
  • Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
  • Formulate appropriate treatment regimens considering the emergence of new investigative agents
  • Provide appropriate care and counsel for patients and their families

Accreditor Disclosure of Conflicts of Interest Policy

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Michael J. Thorpy, MD
Professor of Clinical Neurology
Montefiore Medical Center
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Dr. Thorpy:
Speaker’s Bureau: Jazz, Teva
Consultant: Jazz, Teva

Accredited Provider Disclosure

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following Global Medical Education (GME) planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: Prakash Masand, MD: Consultant: Forest, Lundbeck, Merck, Pamlab, Pfizer, Sunovion, Takeda; Research Support: Forest; Speaker’s Bureau: Forest, GlaxoSmithKline, Lundbeck, Merck, Pamlab, Pfizer, Sunovion, Takeda.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Global Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Postgraduate Institute for Medicine designates this live activity a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.20

Type

CE for Nurses

Accreditation Statement

Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This educational activity for 1.20 contact hours is provided by Postgraduate Institute for Medicine.

California Board of Registered Nurses Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 1.00 contact hour.

Credit

1.00

Type

CE for Nurse Practitioners

Accreditation Statement

This program is approved for 1.00 contact hour of continuing education (which includes 0.36 hours of pharmacology) by the American Association of Nurse Practitioners. Program ID 1501029. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue